To measure serum levels of bevacizumab and to compare serum levels of free vascular endothelial growth factor ( VEGF ) and insulin-like growth factor-1 ( IGF-1 ) in infants who were treated with either intravitreal injection of bevacizumab ( IVB ) or laser for type 1 retinopathy of prematurity ( ROP ) .